Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,014 public trials 531 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Sargramostim in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission Following Initial Treatment

NCT00072579

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: CCOP - Western Regional, Arizona Phoenix, Arizona, United States

CCOP - Bay Area Tumor Institute Oakland, California, United States

CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States

Regional Radiation Oncology Center at Rome Rome, Georgia, United States

View all 15 locations

View Trial Details

Completed

Primary Thrombocythaemia 1 Trial

NCT00175838

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +12 more
Locations: Addenbrooke's Hospital Cambridge, Cambs, United Kingdom

View Trial Details

Completed

Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)

NCT01259817

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

The Palo Alto Clinic Palo Alto, California, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

Emory Hospital Atlanta, Georgia, United States

View all 21 locations

View Trial Details

Completed

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

NCT01174940

Conditions: Bone Marrow Diseases, Graft Versus Host Disease, Graft vs Host Disease, +17 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

View Trial Details

Completed

A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies

NCT02829775

Conditions: Adenocarcinoma, Bone Marrow Diseases, Carcinoma, +36 more
Locations: Sofia, Bulgaria

Halifax, Nova Scotia, Canada

Lucknow, India

Moscow, Russia

View Trial Details

Completed

Natural History Study of Patients With Chronic Myelogenous Leukemia

NCT00429910

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +16 more
Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)

NCT00136409

Conditions: Agnogenic Myeloid Metaplasia, Bone Marrow Diseases, Chronic Disease, +16 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00104975

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +58 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes

NCT00384956

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.

NCT01250951

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +13 more
Locations: Novartis Investigative Site Moscow, Russia

Novartis Investigative Site Saint Petersburg, Russia

View Trial Details

Bone Marrow Diseases

Bone Marrow Diseases trial results

Related conditions